The Impact of Nutrigenomics on Metabolic Health
The Promise and Challenges of Microbiome Therapeutics
European Commission Grants AbbVie Conditional Marketing Authorization for Epcoritamab to Treat Relapsed/Refractory Follicular Lymphoma in Adults
BerGenBio Partners with Tempus to Advance Development in STK11-Mutant Non-Small Cell Lung Cancer
Danaher Acquires Swiss Life Sciences Software Firm Genedata
EMA Validates Type II Variation Application for ENHERTU® in HER2 Low and Ultralow Metastatic Breast Cancer After Prior Endocrine Therapy
REGENXBIO Reports Encouraging Interim Results from Phase II AAVIATE® Trial of ABBV-RGX-314 for Wet AMD Treatment via Suprachoroidal Delivery
Imfinzi Approved in the US for Pre- and Post-Surgery Treatment of Resectable Non-Small Cell Lung Cancer
"LEQEMBI® (Lecanemab) Receives Approval for Alzheimer's Disease Treatment in the United Arab Emirates"
Universal DX Completes Series B Round to Launch Clinical Trial for Colorectal Cancer Screening Test
Sophia Genetics' DDM Platform Achieves CE Marking
Qure.ai Earns 12th Indian Patent for Advanced Lung Abnormality Detection System
Enhertu Receives Approval in China for HER2-Positive Gastric and Gastroesophageal Junction Cancer
Biocartis Names Dr. W. Michael Korn as Chief Medical and Scientific Officer, Renowned Precision Oncology Expert
RNT Medical College Udaipur to Launch India's First Sickle Cell Wellness Hub